Cargando…

Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial

BACKGROUND: Uncontrolled blood pressure is the leading cause of mortality and disability due to associated cerebral and cardiovascular diseases and kidney failure. More than one-third of the old adult population have hypertension or prehypertension and many of their blood pressure are poorly control...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Tian, Xing, Guoqiang, Zhu, Jingfen, Cai, Yong, Zhang, Shuxian, Xu, Gang, Feng, Yi, Li, Donghua, Rao, Jianyu, Shi, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662493/
https://www.ncbi.nlm.nih.gov/pubmed/31391860
http://dx.doi.org/10.1155/2019/7056872
_version_ 1783439665093672960
author Shen, Tian
Xing, Guoqiang
Zhu, Jingfen
Cai, Yong
Zhang, Shuxian
Xu, Gang
Feng, Yi
Li, Donghua
Rao, Jianyu
Shi, Rong
author_facet Shen, Tian
Xing, Guoqiang
Zhu, Jingfen
Cai, Yong
Zhang, Shuxian
Xu, Gang
Feng, Yi
Li, Donghua
Rao, Jianyu
Shi, Rong
author_sort Shen, Tian
collection PubMed
description BACKGROUND: Uncontrolled blood pressure is the leading cause of mortality and disability due to associated cerebral and cardiovascular diseases and kidney failure. More than one-third of the old adult population have hypertension or prehypertension and many of their blood pressure are poorly controlled. OBJECTIVE: We hypothesized that plant extracts-based antioxidants may benefit those with prehypertension/hypertension. METHOD: One hundred age- and gender-matched healthy older adults were randomly assigned to receive HyperBalance capsules (n=50) or placebo (n=50) at Tang-Qiao Community Health Service Center, Shanghai. Blood pressure and severity scores of hypertension treatment-related symptoms (dizziness, headache, ringing/buzzing in ears, rapid heart rate, and chest tightness) were evaluated before and after the 12-week intervention. RESULTS: Ninety-eight people completed the study, with 2 dropouts in the placebo group before the end of the study. Forty-one subjects (82%) of the HyperBalance group and 40 subjects (83.3%) of the placebo group had prehypertension (systolic blood pressures (SBP) between 130-139 and diastolic blood pressure (DBP) between 85-89mmHg), and 9 subjects (18%) in the HyperBalance group and 8 subjects (16.7%) in the placebo group had hypertension (≥140/90mmHg) before the intervention. HyperBalance significantly (P<0.01) reduced SBP from 136.18±4.38 to 124.14±3.96 mmHg and reduced DBP from 82.45±2.91 to 80.24±2.41mmHg, respectively, and reversed all 9 hypertension people to normotension or prehypertension state, whereas the placebo moderately reduced SBP from 135.79±4.22 to 132.35±4.656mmHg and reduced DBP from 82.90±3.07 to 82.27±3.01mmHg. All symptom severity scores became significantly lower in the HyperBalance group than in the placebo group after HyperBalance intervention: dizziness (0.82±0.44; vs 2.02±0.64, P<0.01); headache (0.46±0.50; vs 1.81±0.61, P<0.01); ringing/buzzing in ears (0.44±0.50; vs 1.04±0.29, P<0.01); and rapid heart rate and chest tightness (0.30±0.46; vs 0.92±0.28, P<0.01). CONCLUSION: Polyherbal supplementation such as HyperBalance could benefit old adults with prehypertension/hypertension and improve treatment-related symptoms. Further studies are needed to validate the current findings.
format Online
Article
Text
id pubmed-6662493
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-66624932019-08-07 Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial Shen, Tian Xing, Guoqiang Zhu, Jingfen Cai, Yong Zhang, Shuxian Xu, Gang Feng, Yi Li, Donghua Rao, Jianyu Shi, Rong Evid Based Complement Alternat Med Research Article BACKGROUND: Uncontrolled blood pressure is the leading cause of mortality and disability due to associated cerebral and cardiovascular diseases and kidney failure. More than one-third of the old adult population have hypertension or prehypertension and many of their blood pressure are poorly controlled. OBJECTIVE: We hypothesized that plant extracts-based antioxidants may benefit those with prehypertension/hypertension. METHOD: One hundred age- and gender-matched healthy older adults were randomly assigned to receive HyperBalance capsules (n=50) or placebo (n=50) at Tang-Qiao Community Health Service Center, Shanghai. Blood pressure and severity scores of hypertension treatment-related symptoms (dizziness, headache, ringing/buzzing in ears, rapid heart rate, and chest tightness) were evaluated before and after the 12-week intervention. RESULTS: Ninety-eight people completed the study, with 2 dropouts in the placebo group before the end of the study. Forty-one subjects (82%) of the HyperBalance group and 40 subjects (83.3%) of the placebo group had prehypertension (systolic blood pressures (SBP) between 130-139 and diastolic blood pressure (DBP) between 85-89mmHg), and 9 subjects (18%) in the HyperBalance group and 8 subjects (16.7%) in the placebo group had hypertension (≥140/90mmHg) before the intervention. HyperBalance significantly (P<0.01) reduced SBP from 136.18±4.38 to 124.14±3.96 mmHg and reduced DBP from 82.45±2.91 to 80.24±2.41mmHg, respectively, and reversed all 9 hypertension people to normotension or prehypertension state, whereas the placebo moderately reduced SBP from 135.79±4.22 to 132.35±4.656mmHg and reduced DBP from 82.90±3.07 to 82.27±3.01mmHg. All symptom severity scores became significantly lower in the HyperBalance group than in the placebo group after HyperBalance intervention: dizziness (0.82±0.44; vs 2.02±0.64, P<0.01); headache (0.46±0.50; vs 1.81±0.61, P<0.01); ringing/buzzing in ears (0.44±0.50; vs 1.04±0.29, P<0.01); and rapid heart rate and chest tightness (0.30±0.46; vs 0.92±0.28, P<0.01). CONCLUSION: Polyherbal supplementation such as HyperBalance could benefit old adults with prehypertension/hypertension and improve treatment-related symptoms. Further studies are needed to validate the current findings. Hindawi 2019-07-14 /pmc/articles/PMC6662493/ /pubmed/31391860 http://dx.doi.org/10.1155/2019/7056872 Text en Copyright © 2019 Tian Shen et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shen, Tian
Xing, Guoqiang
Zhu, Jingfen
Cai, Yong
Zhang, Shuxian
Xu, Gang
Feng, Yi
Li, Donghua
Rao, Jianyu
Shi, Rong
Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial
title Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial
title_full Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial
title_fullStr Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial
title_full_unstemmed Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial
title_short Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial
title_sort effects of 12-week supplementation of a polyherbal formulation in old adults with prehypertension/hypertension: a randomized, double-blind, placebo-controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662493/
https://www.ncbi.nlm.nih.gov/pubmed/31391860
http://dx.doi.org/10.1155/2019/7056872
work_keys_str_mv AT shentian effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial
AT xingguoqiang effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial
AT zhujingfen effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial
AT caiyong effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial
AT zhangshuxian effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial
AT xugang effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial
AT fengyi effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial
AT lidonghua effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial
AT raojianyu effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial
AT shirong effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial